Kimberly Dahlman, PhD, associate professor of Medicine in the Division of Hematology and Oncology, will begin serving her three-year term upon the closing of the association’s annual conference on June 17.
John Sergent, MD, Professor of Medicine (Rheumatology and Immunology), who first came to Vanderbilt as an undergraduate student in 1959 and has left an indelible imprint on the University and Medical Center as a student, resident, faculty physician and leader every decade since, is retiring on April 30
Research published in JAMA Dermatology by VUMC investigators, including senior corresponding author Douglas Johnson, MD, MSCI (Hematology and Oncology), provides insight into chronic cirAEs.
Researchers at Vanderbilt University Medical Center, including Milner Staub, MD, MPH (Infectious Diseases), have been awarded a five-year, $4.1 million grant from the National Institutes of Health to assess antibiotic prescriptions and antimicrobial stewardship in unplanned care spaces across Vanderbilt Health.
Vanderbilt University Medical Center has been funded by the Patient-Centered Outcomes Research Institute (PCORI) to implement a team-based, primary care approach to controlling high blood pressure, or hypertension.
Nicholas Markham, MD, PhD (Gastroenterology, Hepatology and Nutrition), and colleagues are exploring how bacteria in the colon may contribute to cancer development.
A research team led by investigators at VUMC, including Department of Medicine Dr. Jennifer (Piper) Below (Genetic Medicine), has identified a set of inflammatory genes that contribute to severe obesity.
Faculty members Drs. Elizabeth Phillips (Infectious diseases) and Michael Savona (Hematology and Oncology) are among the six Vanderbilt University faculty members that have been elected fellows of the American Association for the Advancement of Science.
He will receive the John W. Walsh PAR Award for Excellence, which honors individuals who embody compassion for patients, innovative spirit and outstanding leadership skills.
